Literature DB >> 11605651

Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.

T Uchida1, Y Toida, S Sakakibara, Y Miyanaga, H Tanaka, M Nishikata, K Tazuya, N Yasuda, K Matsuyama.   

Abstract

The objectives of this study were to prepare insulin-loaded acrylic hydrogel formulations containing various absorption enhancers, to perform in vitro and in vivo characterization of these formulations, and to evaluate the factors which affecting insulin availability on rectal delivery of insulin using this hydrogel system. The acrylic block copolymer of methacrylic acid and methacrylate, Eudispert, was used to make the hydrogel formulations. As absorption enhancers, 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-CyD), lauric acid (C12), or the sodium salt of C12 (C12Na), were incorporated into the hydrogels. In an in vitro release test, the release rate of insulin from the hydrogels decreased as the polymer concentration of the hydrogel increased. The addition of C12Na to the hydrogel further increased the insulin release rate, which was greater at higher concentrations of the enhancer. A portion of the C12Na was found to remain bound to the acrylic polymer in dissolution medium. Serum insulin levels were determined at various time points after the administration of insulin solution or insulin-loaded (50 units/kg body weight) Eudispert hydrogels containing 5% (w/w) of C12, C12Na, or DM-beta-CyD to in situ loops in various regions of the rat intestine. The most effective enhancement of insulin release was observed with formulations containing C12Na. The bioavailability of insulin from the hydrogels was lower than that from the insulin solutions. Hydrogel formulations containing 7% or 10% Eudispert remained in the rectum for 5 h after rectal administration. However, the 5% (w/w) C12Na solution stained with Evan's-blue had diffused out and the dye had reached the upper intestinal tract within 2 h. Finally, the rectal administration of insulin-loaded hydrogels, containing 4%, 7%, or 10% (w/w) Eudispert and 5% (w/w) of enhancer (C12, C12Na, or DM-beta-CyD) to normal rats was shown to decrease serum glucose concentrations. The greatest effect was found with insulin-loaded 7% (Eudispert) hydrogel containing C12Na which having cosiderable large insulin release rate and bioadhesive characteristics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605651     DOI: 10.1248/cpb.49.1261

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration.

Authors:  Eman S El-Leithy; Dalia S Shaker; Mohamed K Ghorab; Rania S Abdel-Rashid
Journal:  AAPS PharmSciTech       Date:  2010-11-25       Impact factor: 3.246

2.  Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery.

Authors:  Chun-Hui Huang; Peng-Yi Hu; Qiu-Yan Wu; Ming-Yan Xia; Wen-Liu Zhang; Zhi-Qiang Lei; Dong-Xun Li; Guo-Song Zhang; Jian-Fang Feng
Journal:  Drug Des Devel Ther       Date:  2022-05-12       Impact factor: 4.319

Review 3.  Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications.

Authors:  Mohsen Doostmohammadi; Atefeh Ameri; Reza Mohammadinejad; Negar Dehghannoudeh; Ibrahim M Banat; Mandana Ohadi; Gholamreza Dehghannoudeh
Journal:  Drug Des Devel Ther       Date:  2019-09-26       Impact factor: 4.162

Review 4.  Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Ju-Suk Nam; George Priya C Doss; Sang-Soo Lee; Chiranjib Chakraborty
Journal:  J Nanobiotechnology       Date:  2015-10-24       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.